H1B Report
Side-by-side comparison

Dana-Farber Cancer Institute vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Dana-Farber Cancer Institute
MARank #FEIN 04-2263040
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDana-Farber Cancer InstituteDeloitte Consulting LLP
Total filings1,92680,813
Certified %74.14%98.23%
Denied %1.92%1.09%
Withdrawn %1.09%0.61%
Cert-withdrawn %22.85%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateMAPA

Outcomes — Dana-Farber Cancer Institute

DOL case-status mix.

Outcome breakdown: Certified 74.1%, Cert-withdrawn 22.8%, Withdrawn 1.1%, Denied 1.9%
Outcome breakdown
OutcomeShare
Certified74.1%
Cert-withdrawn22.8%
Withdrawn1.1%
Denied1.9%
Certified74.1%
Cert-withdrawn22.8%
Withdrawn1.1%
Denied1.9%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Dana-Farber Cancer Institute
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY2010127
FY2011128
FY2012144
FY2013135
FY2014109
FY2015101
FY2016114
FY2017111
FY2018129
FY2019178
FY20200
FY20210
FY20220
FY2023104
FY2024162
FY2025199
FY2026185
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.